Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Body mass index influence interferon-beta treatment response in multiple sclerosis.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Studying the Effects of Semaphorins on Oligodendrocyte Lineage Cells.
Nerve pathologic features differentiate POEMS syndrome from CIDP.
Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling.
Relapses in multiple sclerosis: Relationship to disability.
The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
Phenotyping primary human microglia: tight regulation of LPS responsiveness.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
The topographical model of multiple sclerosis: A dynamic visualization of disease course.
The Advances in Neurobiology.
Acute demyelinating disorders of the central nervous system.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.
The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain.
Pages
« first
‹ previous
…
721
722
723
724
725
726
727
728
729
…
next ›
last »